Benefit-risk tradeoff preferences for chronic hand eczema treatments
Author:
Affiliation:
1. RTI Health Solutions, Research Triangle Park, NC, USA;
2. Steifel, a GSK Company, Research Triangle Park, NC, USA
Funder
Stiefel, a GSK Company
Publisher
Informa UK Limited
Subject
Dermatology
Link
https://www.tandfonline.com/doi/pdf/10.1080/09546634.2016.1177161
Reference28 articles.
1. Contact Dermatitis in the United States: Epidemiology, Economic Impact, and Workplace Prevention
2. Management of chronic hand eczema
3. Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis
4. Recent advances in the management of hand dermatitis: Does alitretinoin work?
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adverse events from topical corticosteroid use in chronic hand eczema — Findings from the Danish Skin Cohort;JAAD International;2024-03
2. Dynamics of Patient-Based Benefit-Risk Assessment of Medicines in Chronic Diseases: A Systematic Review;Patient Preference and Adherence;2022-09
3. Use of Patient Preference Information in Benefit–Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts and Initiatives;Frontiers in Medicine;2020-10-26
4. Physician-Specific Maximum Acceptable Risk in Personalized Medicine: Implications for Medical Decision Making;Medical Decision Making;2018-04-03
5. Hand Eczema: Treatment Options;Current Treatment Options in Allergy;2017-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3